165 related articles for article (PubMed ID: 38267575)
1. Synthesis and biological evaluation of nectriatide derivatives, potentiators of amphotericin B activity.
Nagai K; Kobayashi K; Miyake R; Sato Y; Seki R; Fukuda T; Yagi A; Uchida R; Ohshiro T; Tomoda H
J Antibiot (Tokyo); 2024 Apr; 77(4):214-220. PubMed ID: 38267575
[TBL] [Abstract][Full Text] [Related]
2. Nectriatide, a Potentiator of Amphotericin B Activity from
Fukuda T; Nagai K; Yagi A; Kobayashi K; Uchida R; Yasuhara T; Tomoda H
J Nat Prod; 2019 Oct; 82(10):2673-2681. PubMed ID: 31498627
[TBL] [Abstract][Full Text] [Related]
3. New piericidin rhamnosides as potentiators of amphotericin B activity against Candida albicans produced by actinomycete strain TMPU-A0287.
Yagi A; Yamaguchi Y; Kawasaki K; Usui E; Yamazaki H; Uchida R
J Antibiot (Tokyo); 2023 Feb; 76(2):65-74. PubMed ID: 36460732
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
[TBL] [Abstract][Full Text] [Related]
5. Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158.
Yagi A; Uchida R; Kobayashi K; Tomoda H
J Antibiot (Tokyo); 2020 Apr; 73(4):211-223. PubMed ID: 31974520
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
[TBL] [Abstract][Full Text] [Related]
7. Podogigants A and B, two new potentiators of amphotericin B activity, from Sordariomycete Podostroma giganteum.
Hasegawa M; Hosoya T; Kobayashi K; Tomoda H; Shigemori H
J Nat Med; 2021 Sep; 75(4):877-883. PubMed ID: 33993393
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of antifungal and cytotoxic activities as also the therapeutic safety of the oxidized form of amphotericin B.
Klimek K; Strubińska J; Czernel G; Ginalska G; Gagoś M
Chem Biol Interact; 2016 Aug; 256():47-54. PubMed ID: 27350166
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
10. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.
Tutaj K; Szlazak R; Szalapata K; Starzyk J; Luchowski R; Grudzinski W; Osinska-Jaroszuk M; Jarosz-Wilkolazka A; Szuster-Ciesielska A; Gruszecki WI
Nanomedicine; 2016 May; 12(4):1095-1103. PubMed ID: 26772425
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro.
Chudzik B; Czernel G; Miaskowski A; Gagoś M
Eur J Pharm Sci; 2017 Jan; 97():9-21. PubMed ID: 27816628
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
14. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
15. The Substantial Improvement of Amphotericin B Selective Toxicity Upon Modification of Mycosamine with Bulky Substituents.
Borowski E; Salewska N; Boros-Majewska J; Serocki M; Chabowska I; Milewska MJ; Ziętkowski D; Milewski S
Med Chem; 2020; 16(1):128-139. PubMed ID: 30501601
[TBL] [Abstract][Full Text] [Related]
16. Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains.
Zareshahrabadi Z; Khorram M; Pakshir K; Tamaddon AM; Jafari M; Nouraei H; Ardekani NT; Amirzadeh N; Irajie C; Barzegar A; Iraji A; Zomorodian K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1619-1631. PubMed ID: 36183759
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
Grisin T; Bories C; Bombardi M; Loiseau PM; Rouffiac V; Solgadi A; Mallet JM; Ponchel G; Bouchemal K
Pharm Res; 2017 May; 34(5):1067-1082. PubMed ID: 28168390
[TBL] [Abstract][Full Text] [Related]
18. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
Alvarez C; Shin DH; Kwon GS
Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
[TBL] [Abstract][Full Text] [Related]
19. Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates.
Francis AP; Gurudevan S; Jayakrishnan A
J Biomater Sci Polym Ed; 2018 Sep; 29(13):1529-1548. PubMed ID: 29683392
[TBL] [Abstract][Full Text] [Related]
20. The synergistic fungicidal effect of low-frequency and low-intensity ultrasound with amphotericin B-loaded nanoparticles on C. albicans in vitro.
Yang M; Xie S; Adhikari VP; Dong Y; Du Y; Li D
Int J Pharm; 2018 May; 542(1-2):232-241. PubMed ID: 29559330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
